Rights issue

ChromoGenics

July 17, 2018

Sector

Renewables

Transaction

Naventus acted as financial advisor to ChromoGenics on its rights issue of 86 million.

all transactions
ChromoGenics

Contact us

Would you like to know more about our Corporate Finance services?
Contact our dedicated team.

CORPORATE FINANCE TEAM
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.